Synthesis and biological evaluation of new 3-Aralkylamino-2-aryl-2H- 1,2,4-pyridothiadiazine 1,1-dioxides as potential CCK-Receptor ligands

Journal of Pharmacy and Pharmacology

Volumn 49, Issue 5, 1997, Pages 463-471

  De Tullio, Pascal ^a   Pirotte, Bernard ^a   Neven, Philippe ^a   Masereel, Bernard ^a   Dewalque, Daniel ^a   Diouf, Ousmane ^a   Podona, Tchao ^a   Caignard, Daniel ^b   Renard, Pierre ^b   Delarge, Jacques ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b ADIR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARALKYL 4H PYRIDOTHIADIAZINE 1,1 DIOXIDE; 3 ARALKYLAMINO 2 ARYL 2H 1,2,4 PYRIDOTHIADIAZINE 1,1 DIOXIDE; ASPERLICIN; BENZOTRIPT; BRAIN RECEPTOR; CHOLECYSTOKININ A RECEPTOR ANTAGONIST; CHOLECYSTOKININ B RECEPTOR ANTAGONIST; CHOLECYSTOKININ OCTAPEPTIDE; CHOLECYSTOKININ RECEPTOR; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; LORGLUMIDE; MEMBRANE RECEPTOR; QUINAZOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG RECEPTOR BINDING; DRUG STRUCTURE; DRUG SYNTHESIS; MOUSE; NONHUMAN; PANCREAS; RAT; REACTION ANALYSIS; STRUCTURE ACTIVITY RELATION;

EID: 15644383454     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1997.tb06825.x     Document Type: Article

References (42)

1. Baile, C., McLaughlin, C. L., Della-Ferra, M. A. (1986) Role of cholecystokinin and opioid peptides in control of food intake. Physiol. Rev. 66: 172-234
2. Bell, S. C., Gochman, C., Wei, P. H. (1975) Synthesis of heterocyclic fused thiazolecarboxylic acids I. J. Heterocycl. Chem. 12: 1207-1210
3. Blundell, J. (1991) Pharmacological approaches to appetite suppression. Trends Pharmacol. Sci. 12: 147-157
4. Chang, R. S. L., Lotti, V. J. (1986) Biochemical and pharmacological characterization of a new extremely potent and selective non peptide cholecystokinin antagonist. Proc. Natl Acad. Sci. USA 83: 4923-4926
5. Chang, R. S. L., Lotti, V. J., Monaghan, R. L., Birnbaum, J., Stapley, E. O., Goötz, M. A., Albers-Schonberg, G., Patchett, A. A., Liesch, J. M., Hensens, O. D., Springer, J. P. (1985) A potent nonpeptide cholecystokinin antagonist selective for peripheral tissues isolated from Aspergillus alliaceus. Science 230: 177
6. Cherner, J. A., Sutliff, V. E., Grybowski, D. M., Jensen, R. T., Gardner, J. D. (1988) Functionally distinct receptors for cholecystokinin and gastrin on dispersed chief cells from guinea pig stomach. Am. J. Physiol. 254: G151-G155
7. Crawley, J. N., Corwin, R. L. (1994) Biological actions of cholecystokinin. Peptides 15: 731-755
8. de Tullio, P., Pirotte, B., Dupont, L., Masereel, B., Laeckmann, D., Podona, T., Diouf, O., Lebrun, P., Delarge, J. (1995) Synthesis and structural studies of a new class of heterocyclic compounds: 1,2,4-thiadiazine 1,1-dioxides. Tetrahedron 51: 3221-3234
9. de Tullio, P., Pirotte, B., Lebrun, P., Fontaine, J., Dupont, L., Antoine, M.-H., Ouedraogo, R., Khelili, S., Maggetto, C., Masereel, B., Diouf, O., Podona, T., Delarge, J. (1996) 3- and 4-substituted 4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as potassium-channel openers: synthesis, pharmacological evaluation and structure-activity relationships. J. Med. Chem. 39: 937-948
10. European Patent application (1988) no. 0 268 990 A2
11. Evans, B. E., Rittle, K. E., Bock, M. G., DiPardo, R. M., Freidinger, R. M., Whitter, W. L., Gould, N. P., Lundell, G. F., Hommick, C. F., Veber, D. F., Anderson, P. S., Chang, R. S. L., Lotti, V. J., Cerino, D. J., Chen, T. B., Kling, P. J., Kunkel, K. A., Springer, J. P., Hirshfield, J. (1987) Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists. J. Med. Chem. 30: 1229-1239
12. Freidinger, R. M. (1989) Cholecystokinin and gastrin antagonists. Med. Res. Rev. 9: 271-290
13. Goëtz, M. A., Lopez, M., Monaghan, R. L., Chang, R. S. L., Lotti, V. J., Chen, T. B. (1985) Asperlicin, a novel non-peptidal cholecystokinin antagonist from Aspergillus alliaceus, fermentation, isolation and biological properties. J. Antibiot. 41: 875-877
14. Hahne, W. F., Jensen, R. T., Lemp, G. F., Gardner, J. D. (1981) Proglumide and benzotript members of a different class of cholecystokinin receptor antagonists. Proc. Natl Acad. Sci. USA 78: 6304-6308
15. Hayao, S., Strycker, W., Phillips, B., Fujimori, H., Vidrio, H. (1968) Sedative, antiadrenergic, and hypotensive 2-substituted 2H-1,2,4-benzothiadiazin-3(4H)-one 1,1-dioxides. J. Med. Chem. 11: 1246-1248
16. Hersey, S. J., May, D., Schyberg, D. (1983) Stimulation of pepsinogen release from isolated gastric glands by cholecystokinin-like peptides. Am. J. Physiol. 244: 192-197
17. Iversen, L. L., Dourish, C. T., Iversen, S. D. (1991) Cholecystokinin receptors: synthetic antagonists with selectivity for receptor subtypes and possible clinical applications. Biochem. Soc. Trans. 19: 913-915
18. Jensen, R. T., Wank, S. A., Rowley, W. H., Sato, S., Gardner, J. D. (1989) Interaction of CCK with pancreatic acinar cells. Trends Pharmacol. Sci. 10: 418-423
19. Lejeune, R., Delarge, J., Thunus, L. (1984). Preparation de disulphure de mercapto-3-pyridinesulphonamide-2. J. Pharm. Belg. 39: 217-224
20. Liddle, R. A., Gertz, B. J., Kanayama, S., Beccaria, L., Coker, L. D., Turnbull, T. A. (1989) Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implication for the physiology of CCK. J. Clin. Invest. 84: 1220-1225
21. Louie, D. S., Liang, J. P., Owyang, C. (1988) Characterization of a new CCK antagonist, L-364-718: in vitro and in vivo studies. Am. J. Physiol. 255: 261-266
22. Makovec, F., Chisté, R., Bani, M., Revel, L., Setnikar, I., Rovati, L. A. (1986) New glutamic and aspartic derivatives with potent CCK-antagonistic activity. Eur. J. Med. Chem. Chim. Ther. 21: 9-20
23. McRoberts, J. W. (1986) Cholecystokinin and pain: a review. Anesth. Prog. 33: 87-90
24. Moran, T. H., Robinson, P. H., Goldrich, M. S., McHugh, P. R. (1986) Two brain cholecystokinin receptors: implications for behavioural actions. Brain Res. 362: 175-179
25. Nadzan, A. M., Kerwin, J. F. (1991) Cholecystokinin agonists and antagonists. Ann. Rep. Med. Chem. 20: 191-200
26. Patel, S., Smith, A. J., Chapman, K. L., Fletcher, A. E., Kemp, J. A., Marshall, G. R., Hargreaves, R. J., Ryecroft, W., Iversen, L. L., Iversen, S. D., Baker, R., Showell, G. A., Bourrain, S., Eduvelil, J. G., Matassa, V. G., Freedman, S. B. (1994) Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivo. Mol. Pharmacol. 46: 943-948
27. Petersen, H. J. (1973) Synthesis of 3-amino- and 3-substituted amino-2H-1,2,4-benzothiadiazine 1,1-dioxides. Acta Chem. Scand. 27: 2655-2660
28. Pirotte, B., Masereel, B., Schynts, M., Delarge, J. (1990) Les sulfamides diurétiques: des origines aux perspectives d'avenir. Chimie Nouvelle 8: 920-924
29. Pirotte, B., de Tullio, P., Lebrun, P., Antoine, M.-H., Fontaine, J., Masereel, B., Schynts, M., Dupont, L., Herchuelz, A., Delarge, J. (1993) 3-(Alkylamino)-4H-pyrido[4,3-e]-1,2,4-thiadiazine 1,1-dioxides as powerful inhibitors of insulin release from rat pancreatic B-cells: a new class of potassium channel openers? J. Med. Chem. 36: 3211-3213
30. Raffa, L., Di Bella, M., Melegari, M., Vampa, G. (1962) Ricerche nel campo della 1,2,4-benzotiadiazina. Il Farmaco 18: 331-339
31. Rehfeld, J. F., Larsson, L. I., Goltermann, N. R., Schwartz, T. W., Holst, J. J., Jensen, S. L., Morley, J. S. (1980) Neural regulation of pancreatic hormone secretion of C-terminal tetrapeptide of CCK. Nature 284: 33-38
32. Satoh, M., Kondoh, Y., Okamoto, Y., Nishida, A., Miyata, K., Ohta, M., Mase, T., Murase, K. (1995) New 1,4-benzodiazepin-2-one derivatives as gastrin/cholecystokinin-B antagonists. Chem. Pharm. Bull. 43: 2159-2167
33. Singh, L., Lewis, A. S., Field, M. J., Hughes, J., Woodruff, G. N. (1991) Evidence for an involvement of the brain cholecystokinin B receptor in anxiety. Proc. Natl. Acad. Sci. USA 88: 1130-1133
34. 3H]-cholecystokinin-8 as radioligand. J. Neurosci. 4: 1021-1033
35. 1) receptor antagonists. Bioorg. Med. Chem. Lett. 2: 115-112
36. West German Patent (1972) No. 2 155 483; Chem. Abstr. 77: 66325
37. Wettstein, J. G., Buèno, L., Junien, J. L. (1994) CCK antagonists: pharmacology and therapeutic interest. Pharmacol. Ther. 62: 267-282
38. Wollweber, H., Horstmann, H., Stoepel, K., Garthoff, B., Puls, W., Krause, H. P., Thomas, G. (1981) 3-Amino-2H-1,2,4-benzothiadiazine-1,1-dioxide mit antihypertensiver und potentieller diabetogener Wirkung. Arzneimittelforschung 31: 279-288
39. Woodruff, G. N., Hughes, J. (1991) Cholecystokinin antagonist. Ann. Rev. Pharmacol. Toxicol. 31: 469-501
40. Yu, D. H., Huang, S. C., Wank, S. A., Mantey, S., Gardner, J. D., Jensen, R. T. (1990) Pancreatic receptors for cholecystokinin: evidence for three receptor classes. Am. J. Physiol. 258: G86-G95
41. Yu, M. J., Thrasher, K. J., McCowan, J. R., Mason, N. R., Mendelsohn, L. G. (1991) Quinazolinone cholecystokinin-B receptor ligands. J. Med. Chem. 34: 1505-1508
42. Yu, M. J., McCowan, J. R., Mason, N. R., Deeter, J. B., Mendelsohn, L. G. (1992) Synthesis and X-ray crystallographic analysis of quinazolinone cholecystokinin: gastrin receptor ligands. J. Med. Chem. 35: 2534-2542